Generali Investments Management Co LLC Makes New $1.37 Million Investment in Colgate-Palmolive (NYSE:CL)

Generali Investments Management Co LLC acquired a new stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 15,095 shares of the company's stock, valued at approximately $1,372,000.

A number of other institutional investors have also recently made changes to their positions in CL. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $26,000. Centricity Wealth Management LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $27,000. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Briaud Financial Planning Inc purchased a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $33,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock traded up $0.02 during mid-day trading on Friday, reaching $90.30. 8,950,637 shares of the company's stock traded hands, compared to its average volume of 4,226,202. The company has a market cap of $73.28 billion, a price-to-earnings ratio of 25.65, a PEG ratio of 4.20 and a beta of 0.40. The stock has a 50 day moving average of $89.33 and a two-hundred day moving average of $94.18. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30.

Remove Ads

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the business earned $0.87 EPS. Equities analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be paid a $0.52 dividend. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 56.82%.

Colgate-Palmolive declared that its Board of Directors has approved a share buyback program on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its shares are undervalued.

Analyst Ratings Changes

A number of analysts have commented on CL shares. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a report on Tuesday, January 7th. StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Friday, March 14th. TD Cowen dropped their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the stock an "overweight" rating in a research report on Friday, March 14th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $101.72.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.